wegovy a glp 1 GLP-1 weight loss drugs may be misused by patients with eating disorders: Study POTD: Wegovy and Ozempic —

The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients

doi: 10.1016/S0165-2427(96)05743-1 20 SuriyasathapornWDaemenANoordhuizen-StassenEDielemanSNielenMSchukkenY

The drug is available in both injectable and oral forms

Glp-1 Supplement Regional Outlook North America GLP-1 Supplement Market North America: Market Dominance Led by Advanced Pharmacy Retail Infrastructure and Supporting Strong Demand for Protein, Hydration, and Digestive-Support Supplements The North America GLP-1 supplement market accounted for the largest regional share of 41.32% in 2025 due to GLP-1 prescription growth, advanced pharmacy retail infrastructure, and increasing demand for companion metabolic nutrition products

In addition, alcohol cue-induced activation in reward-related brain areas was reduced in the exenatide group compared to the placebo group (Klausen et al